Loading...
By the Editors
Here's some of the top COVID-19 news of the week:
This week, the National Institutes of Health updated its guidelines on treating COVID-19, including new information on the use of colchicine and other therapies. Elsewhere, the FDA revoked its emergency use authorization for the monoclonal antibody bamlanivimab as a monotherapy for COVID-19.
In addition, early results indicate that COVID-19 vaccination appears to be safe in the third trimester of pregnancy, according to a CDC study.
Catch up on these and all of our COVID-19 stories from the past week at the links below.
Comment
LINK(S):
NIH Updates COVID-19 Treatment Guidelines (Apr. 22) (Free)
COVID-19 Vaccines: Safety in Pregnancy / J&J Data / Breakthrough Infections / Skilled Nursing Facilities (Apr. 21) (Free)
EU Regulators Call for Warning on J&J COVID-19 Vaccine (Apr. 20) (Free)
COVID-19: Reinfection Risk / Bamlanivimab Authorization Revoked (Apr. 19) (Free)